CAR-T cell cancer immunotherapy gets personal Feb 14 2023 - 15:16 Reopening the Shiraz Comprehensive Center of Stem Cells and Regenerative Medicine Feb 14 2023 - 13:35 List of U.S. FDA Approved Cell and Gene Therapy Products Feb 14 2023 - 11:10 Rocket Pharmaceuticals receives FDA RMAT designation for Danon disease gene therapy treatment Feb 13 2023 - 15:38 Scientists regenerate diseased kidney cells Feb 12 2023 - 14:49 FDA OKs Study of Novel CAR-T Cell Therapy for Myeloma Feb 12 2023 - 14:47 Stem cells provide a model to understand sensorineural hearing loss Feb 8 2023 - 15:21 Senti Streamline Their CAR-NK Cell Therapy Program to Focus on Acute Myeloid Leukaemia Feb 6 2023 - 15:17 The Future Forecast for MSC-Based Therapeutics Feb 6 2023 - 14:58 First leukemia patient dosed with SMART101 Feb 5 2023 - 13:28
Reopening the Shiraz Comprehensive Center of Stem Cells and Regenerative Medicine Feb 14 2023 - 13:35
Rocket Pharmaceuticals receives FDA RMAT designation for Danon disease gene therapy treatment Feb 13 2023 - 15:38
Senti Streamline Their CAR-NK Cell Therapy Program to Focus on Acute Myeloid Leukaemia Feb 6 2023 - 15:17